{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:10:29Z","timestamp":1780985429168,"version":"3.54.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11154-016-9378-8","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T03:04:18Z","timestamp":1472526258000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Skin manifestations of growth hormone-induced diseases"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6942-6470","authenticated-orcid":false,"given":"Christina","family":"Kanaka-Gantenbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kogia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Badawy","family":"Abdel-Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"key":"9378_CR1","doi-asserted-by":"crossref","unstructured":"Herrington, J. and C. Carter-Su, Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab, 2001. 12(6): p. 252\u20137.","DOI":"10.1016\/S1043-2760(01)00423-4"},{"key":"9378_CR2","doi-asserted-by":"crossref","unstructured":"Brooks, A.J. and M.J. Waters, The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol, 2010. 6(9): p. 515\u201325.","DOI":"10.1038\/nrendo.2010.123"},{"key":"9378_CR3","unstructured":"Gunawardane K et al. Normal Physiology of Growth Hormone in Adults. In: Endotext LJ, Groot D, et al., editors. . South Dartmouth (MA): MDText.com, Inc.; 2000."},{"issue":"2","key":"9378_CR4","doi-asserted-by":"crossref","first-page":"T123","DOI":"10.1530\/JOE-15-0120","volume":"226","author":"PG Murray","year":"2015","unstructured":"Murray PG, Higham CE, Clayton PE. 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60\u00a0years. J Endocrinol. 2015;226(2):T123\u201340.","journal-title":"J Endocrinol"},{"issue":"2","key":"9378_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/edrv-8-2-115","volume":"8","author":"MB Davidson","year":"1987","unstructured":"Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 1987;8(2):115\u201331.","journal-title":"Endocr Rev"},{"issue":"6","key":"9378_CR6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.clnu.2009.08.015","volume":"28","author":"N Moller","year":"2009","unstructured":"Moller N et al. Growth hormone and protein metabolism. Clin Nutr. 2009;28(6):597\u2013603.","journal-title":"Clin Nutr"},{"issue":"1","key":"9378_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14310\/horm.2002.11109","volume":"3","author":"CC Zouboulis","year":"2004","unstructured":"Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones (Athens). 2004;3(1):9\u201326.","journal-title":"Hormones (Athens)"},{"issue":"5\u20136","key":"9378_CR8","first-page":"230","volume":"54","author":"CC Zouboulis","year":"2000","unstructured":"Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res. 2000;54(5\u20136):230\u201342.","journal-title":"Horm Res"},{"issue":"5","key":"9378_CR9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4161\/derm.1.5.9499","volume":"1","author":"CC Zouboulis","year":"2009","unstructured":"Zouboulis CC. The skin as an endocrine organ. Dermatoendocrinol. 2009;1(5):250\u20132.","journal-title":"Dermatoendocrinol"},{"issue":"3","key":"9378_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/1523-1747.ep12616668","volume":"99","author":"A Tavakkol","year":"1992","unstructured":"Tavakkol A et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol. 1992;99(3):343\u20139.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"9378_CR11","first-page":"1368","volume":"75","author":"SR Oakes","year":"1992","unstructured":"Oakes SR et al. Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab. 1992;75(5):1368\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9378_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1260467","volume":"126","author":"PE Lobie","year":"1990","unstructured":"Lobie PE et al. Localization of the growth hormone receptor\/binding protein in skin. J Endocrinol. 1990;126(3):467\u201371.","journal-title":"J Endocrinol"},{"issue":"3","key":"9378_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jcem-55-3-434","volume":"55","author":"RG Rosenfeld","year":"1982","unstructured":"Rosenfeld RG, Dollar LA. Characterization of the somatomedin-C\/insulin-like growth factor I (SM-C\/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C\/IGF-I and insulin. J Clin Endocrinol Metab. 1982;55(3):434\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"9378_CR14","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1210\/endo.140.9.6957","volume":"140","author":"D Deplewski","year":"1999","unstructured":"Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology. 1999;140(9):4089\u201394.","journal-title":"Endocrinology"},{"issue":"4","key":"9378_CR15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","volume":"21","author":"D Deplewski","year":"2000","unstructured":"Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21(4):363\u201392.","journal-title":"Endocr Rev"},{"issue":"2","key":"9378_CR16","first-page":"1","volume":"5","author":"HY Su","year":"1999","unstructured":"Su HY et al. Insulin-like growth factor 1 and hair growth. Dermatol Online J. 1999;5(2):1.","journal-title":"Dermatol Online J"},{"issue":"6","key":"9378_CR17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/1523-1747.ep12340934","volume":"109","author":"SM Rudman","year":"1997","unstructured":"Rudman SM et al. The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol. 1997;109(6):770\u20137.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"9378_CR18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/er.2002-0021","volume":"24","author":"SR Edmondson","year":"2003","unstructured":"Edmondson SR et al. Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems. Endocr Rev. 2003;24(6):737\u201364.","journal-title":"Endocr Rev"},{"issue":"2","key":"9378_CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/joe.0.1540319","volume":"154","author":"AB Lemmey","year":"1997","unstructured":"Lemmey AB et al. Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol. 1997;154(2):319\u201328.","journal-title":"J Endocrinol"},{"key":"9378_CR20","doi-asserted-by":"crossref","unstructured":"Lewis, D.A., et al., The IGF-1\/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene, 2010. 29(10): p. 1475\u201385.","DOI":"10.1038\/onc.2009.440"},{"issue":"24","key":"9378_CR21","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S. Medical progress: Acromegaly. N Engl J Med. 2006;355(24):2558\u201373.","journal-title":"N Engl J Med"},{"issue":"12","key":"9378_CR22","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1210\/jcem.84.12.6222","volume":"84","author":"EA Eugster","year":"1999","unstructured":"Eugster EA, Pescovitz OH. Gigantism. J Clin Endocrinol Metab. 1999;84(12):4379\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9378_CR23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.clindermatol.2006.04.011","volume":"24","author":"A Ben-Shlomo","year":"2006","unstructured":"Ben-Shlomo A, Melmed S. Skin manifestations in acromegaly. Clin Dermatol. 2006;24(4):256\u20139.","journal-title":"Clin Dermatol"},{"issue":"10","key":"9378_CR24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-4362.2002.01638.x","volume":"41","author":"SA Centurion","year":"2002","unstructured":"Centurion SA, Schwartz RA. Cutaneous signs of acromegaly. Int J Dermatol. 2002;41(10):631\u20134.","journal-title":"Int J Dermatol"},{"issue":"10","key":"9378_CR25","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1001\/archinte.1982.00340230060013","volume":"142","author":"LY Matsuoka","year":"1982","unstructured":"Matsuoka LY et al. Histochemical characterization of the cutaneous involvement of acromegaly. Arch Intern Med. 1982;142(10):1820\u20133.","journal-title":"Arch Intern Med"},{"issue":"10","key":"9378_CR26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-4362.1991.tb02615.x","volume":"30","author":"DG Diven","year":"1991","unstructured":"Diven DG, Tanus T, Raimer SS. Cutis Verticis Gyrata. Int J Dermatol. 1991;30(10):710\u20132.","journal-title":"Int J Dermatol"},{"issue":"1","key":"9378_CR27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/S0365-05962012000100031","volume":"87","author":"M Resende","year":"2012","unstructured":"Resende M et al. Prevalence of dermatologic disorders in 15 patients with acromegaly. An Bras Dermatol. 2012;87(1):166\u20138.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"9378_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1015713732717","volume":"13","author":"D Baris","year":"2002","unstructured":"Baris D et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control. 2002;13(5):395\u2013400.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"9378_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2265.1997.2001010.x","volume":"47","author":"JB Corcuff","year":"1997","unstructured":"Corcuff JB et al. Ocular naevus and melanoma in acromegaly. Clin Endocrinol. 1997;47(1):119\u201321.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"9378_CR30","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1365-2133.2002.05150.x","volume":"147","author":"D Torley","year":"2002","unstructured":"Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. Br J Dermatol. 2002;147(6):1096\u2013101.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"9378_CR31","first-page":"145","volume":"31","author":"C Demirkesen","year":"2015","unstructured":"Demirkesen C. Skin Manifestations of Endocrine Diseases. Turk Patoloji Derg. 2015;31(Suppl 1):145\u201354.","journal-title":"Turk Patoloji Derg"},{"issue":"6","key":"9378_CR32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.mcna.2009.08.008","volume":"93","author":"MS Lolis","year":"2009","unstructured":"Lolis MS, Bowe WP, Shalita AR. Acne and Systemic Disease. Med Clin N Am. 2009;93(6):1161\u201381.","journal-title":"Med Clin N Am"},{"issue":"6402","key":"9378_CR33","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1136\/bmj.287.6402.1346-a","volume":"287","author":"RJ Chalmers","year":"1983","unstructured":"Chalmers RJ et al. Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J (Clin Res Ed). 1983;287(6402):1346\u20137.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"9378_CR34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ghir.2012.02.006","volume":"22","author":"M Borlu","year":"2012","unstructured":"Borlu M et al. Acromegaly is associated with decreased skin transepidermal water loss and temperature, and increased skin pH and sebum secretion partially reversible after treatment. Growth Hormon IGF Res. 2012;22(2):82\u20136.","journal-title":"Growth Hormon IGF Res"},{"issue":"8","key":"9378_CR35","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jcem.84.8.5858","volume":"84","author":"GA Kaltsas","year":"1999","unstructured":"Kaltsas GA et al. Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab. 1999;84(8):2731\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"9378_CR36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1024\/0040-5930\/a000108","volume":"67","author":"C Henzen","year":"2010","unstructured":"Henzen C. A gentle giant. Ther Umsch. 2010;67(12):623\u20137.","journal-title":"Ther Umsch"},{"issue":"5","key":"9378_CR37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2265.2000.01141.x","volume":"53","author":"SB Sneppen","year":"2000","unstructured":"Sneppen SB et al. Sweat secretion rates in growth hormone disorders. Clin Endocrinol. 2000;53(5):601\u20138.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"9378_CR38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1530\/eje.0.1450147","volume":"145","author":"M Lange","year":"2001","unstructured":"Lange M et al. Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol. 2001;145(2):147\u201353.","journal-title":"Eur J Endocrinol"},{"issue":"1\u20132","key":"9378_CR39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1566-0702(01)00257-0","volume":"89","author":"W Hasan","year":"2001","unstructured":"Hasan W et al. The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly. Auton Neurosci. 2001;89(1\u20132):100\u20139.","journal-title":"Auton Neurosci"},{"issue":"1","key":"9378_CR40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1054\/ghir.2002.0258","volume":"12","author":"M Krsek","year":"2002","unstructured":"Krsek M et al. The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients. Growth Hormon IGF Res. 2002;12(1):54\u20139.","journal-title":"Growth Hormon IGF Res"},{"key":"9378_CR41","doi-asserted-by":"crossref","unstructured":"Schiavon, F., et al., Morphologic study of microcirculation in acromegaly by capillaroscopy. J Clin Endocrinol Metab, 1999. 84(9): p. 3151\u20135.","DOI":"10.1210\/jc.84.9.3151"},{"issue":"3","key":"9378_CR42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0889-8529(18)30206-8","volume":"21","author":"WH Daughaday","year":"1992","unstructured":"Daughaday WH. Pituitary gigantism. Endocrinol Metab Clin N Am. 1992;21(3):633\u201347.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"6","key":"9378_CR43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3476(05)81966-3","volume":"120","author":"SJ Gelber","year":"1992","unstructured":"Gelber SJ, Heffez DS, Donohoue PA. Pituitary gigantism caused by growth hormone excess from infancy. J Pediatr. 1992;120(6):931\u20134.","journal-title":"J Pediatr"},{"issue":"1","key":"9378_CR44","first-page":"216","volume":"76","author":"D Zimmerman","year":"1993","unstructured":"Zimmerman D et al. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab. 1993;76(1):216\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9378_CR45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/edrv-9-3-357","volume":"9","author":"T Sano","year":"1988","unstructured":"Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev. 1988;9(3):357\u201373.","journal-title":"Endocr Rev"},{"issue":"Suppl 2","key":"9378_CR46","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/annonc\/12.suppl_2.S89","volume":"12","author":"M Doga","year":"2001","unstructured":"Doga M et al. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. Ann Oncol. 2001;12(Suppl 2):S89\u201394.","journal-title":"Ann Oncol"},{"issue":"5","key":"9378_CR47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM199008023230507","volume":"323","author":"A Moran","year":"1990","unstructured":"Moran A et al. Gigantism due to pituitary mammosomatotroph hyperplasia. N Engl J Med. 1990;323(5):322\u20137.","journal-title":"N Engl J Med"},{"issue":"6","key":"9378_CR48","first-page":"1675","volume":"82","author":"I Shimon","year":"1997","unstructured":"Shimon I, Melmed S. Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab. 1997;82(6):1675\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9378_CR49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S0317167100033990","volume":"25","author":"MM Feldkamp","year":"1998","unstructured":"Feldkamp MM, Gutmann DH, Guha A. Neurofibromatosis type 1: piecing the puzzle together. Can J Neurol Sci. 1998;25(3):181\u201391.","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"9378_CR50","first-page":"20","volume":"44","author":"DH Ledbetter","year":"1989","unstructured":"Ledbetter DH et al. Precise localization of NF1 to 17q11.2 by balanced translocation. Am J Hum Genet. 1989;44(1):20\u20134.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9378_CR51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152a","author":"DG Evans","year":"2010","unstructured":"Evans DG et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152a(2):327\u201332.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"9378_CR52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","volume":"33","author":"MH Shen","year":"1996","unstructured":"Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1. J Med Genet. 1996;33(1):2\u201317.","journal-title":"J Med Genet"},{"issue":"3","key":"9378_CR53","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ana.410150318","volume":"15","author":"MS Duchowny","year":"1984","unstructured":"Duchowny MS, Katz R, Bejar RL. Hypothalamic mass and gigantism in neurofibromatosis: treatment with bromocriptine. Ann Neurol. 1984;15(3):302\u20134.","journal-title":"Ann Neurol"},{"key":"9378_CR54","volume-title":"Gigantism","author":"E Eugster","year":"2000","unstructured":"Eugster E. In: Endotext LJ, Groot D, et al., editors. Gigantism. South Dartmouth (MA).: MDText.com, Inc; 2000."},{"key":"9378_CR55","doi-asserted-by":"crossref","unstructured":"Nunley, K.S., et al., Predictive value of cafe au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Arch Dermatol, 2009. 145(8): p. 883\u20137.","DOI":"10.1001\/archdermatol.2009.169"},{"issue":"6","key":"9378_CR56","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.90.6.924","volume":"90","author":"BR Korf","year":"1992","unstructured":"Korf BR. Diagnostic outcome in children with multiple cafe au lait spots. Pediatrics. 1992;90(6):924\u20137.","journal-title":"Pediatrics"},{"issue":"6","key":"9378_CR57","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0190-9622(99)70075-7","volume":"40","author":"M Landau","year":"1999","unstructured":"Landau M, Krafchik BR. The diagnostic value of caf\u00e9-au-lait macules. J Am Acad Dermatol. 1999;40(6):877\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"9378_CR58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0022-5320(74)80048-1","volume":"48","author":"K Konrad","year":"1974","unstructured":"Konrad K, Wolff K, Honigsmann H. The giant melanosome: a model of deranged melanosome-morphogenesis. J Ultrastruct Res. 1974;48(1):102\u201323.","journal-title":"J Ultrastruct Res"},{"issue":"2","key":"9378_CR59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/1523-1747.ep12263325","volume":"83","author":"H Nakagawa","year":"1984","unstructured":"Nakagawa H et al. The nature and origin of the melanin macroglobule. J Invest Dermatol. 1984;83(2):134\u20139.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"9378_CR60","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.7326\/0003-4819-61-6-1142","volume":"61","author":"FW Crowe","year":"1964","unstructured":"Crowe FW. Axillary Freckling as a Diagnostic Aid in Neurofibromatosis. Ann Intern Med. 1964;61(6):1142\u20133.","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"9378_CR61","first-page":"623","volume":"19","author":"A Christoforidis","year":"2006","unstructured":"Christoforidis A, Maniadaki I, Stanhope R. McCune-Albright syndrome: growth hormone and prolactin hypersecretion. J Pediatr Endocrinol Metab. 2006;19(Suppl 2):623\u20135.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"24","key":"9378_CR62","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688\u201395.","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"9378_CR63","first-page":"875","volume":"15","author":"S Lumbroso","year":"2002","unstructured":"Lumbroso S, Paris F, Sultan C. McCune-Albright syndrome: molecular genetics. J Pediatr Endocrinol Metab. 2002;15(Suppl 3):875\u201382.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"9378_CR64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-3-12","volume":"3","author":"CE Dumitrescu","year":"2008","unstructured":"Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis. 2008;3:12.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"9378_CR65","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1. J Clin Endocrinol Metab. 2012;97(9):2990\u20133011.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"9378_CR66","first-page":"4776","volume":"85","author":"CA Stratakis","year":"2000","unstructured":"Stratakis CA et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2000;85(12):4776\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9378_CR67","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1997.03890430067009","volume":"133","author":"TN Darling","year":"1997","unstructured":"Darling TN et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol. 1997;133(7):853\u20137.","journal-title":"Arch Dermatol"},{"issue":"7","key":"9378_CR68","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archderm.1986.01660190068018","volume":"122","author":"JA Carney","year":"1986","unstructured":"Carney JA, Headington JT, Su WP. Cutaneous myxomas. A major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol. 1986;122(7):790\u20138.","journal-title":"Arch Dermatol"},{"issue":"1","key":"9378_CR69","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1210\/jc.2013-3159","volume":"99","author":"P Salpea","year":"2014","unstructured":"Salpea P et al. Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing. J Clin Endocrinol Metab. 2014;99(1):E183\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9378_CR70","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2005-2708","volume":"91","author":"L Groussin","year":"2006","unstructured":"Groussin L et al. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab. 2006;91(5):1943\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9378_CR71","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI10841","volume":"106","author":"M Casey","year":"2000","unstructured":"Casey M et al. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest. 2000;106(5):R31\u20138.","journal-title":"J Clin Invest"},{"issue":"3","key":"9378_CR72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI118467","volume":"97","author":"CA Stratakis","year":"1996","unstructured":"Stratakis CA et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Investig. 1996;97(3):699\u2013705.","journal-title":"J Clin Investig"},{"key":"9378_CR73","doi-asserted-by":"publisher","unstructured":"Correa R, Salpea P, Stratakis CA. Carney complex: an update. Eur J Endocrinol. 2015;173(4):M85\u201397. doi: 10.1530\/EJE-15-0209 .","DOI":"10.1530\/EJE-15-0209"},{"issue":"9","key":"9378_CR74","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","volume":"86","author":"CA Stratakis","year":"2001","unstructured":"Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001;86(9):4041\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9378_CR75","first-page":"3860","volume":"85","author":"SD Pack","year":"2000","unstructured":"Pack SD et al. Genetic and Histologic Studies of Somatomammotropic Pituitary Tumors in Patients with the \u201cComplex of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity and Schwannomas\u201d (Carney Complex). J Clin Endocrinol Metabolism. 2000;85(10):3860\u20135.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"9378_CR76","doi-asserted-by":"publisher","unstructured":"Lodish MB, Trivellin G, Stratakis CA. Pituitary gigantism: update on molecular biology and management. Curr Opin Endocrinol Diabetes Obes. 2016;23(1):72\u201380. doi: 10.1097\/MED.0000000000000212 .","DOI":"10.1097\/MED.0000000000000212"},{"issue":"11","key":"9378_CR77","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03346742","volume":"35","author":"F Martucci","year":"2012","unstructured":"Martucci F, Trivellin G, Korbonits M. Familial isolated pituitary adenomas: an emerging clinical entity. J Endocrinol Investig. 2012;35(11):1003\u201314.","journal-title":"J Endocrinol Investig"},{"issue":"25","key":"9378_CR78","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin G et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med. 2014;371(25):2363\u201374.","journal-title":"N Engl J Med"},{"key":"9378_CR79","volume-title":"Adult Growth Hormone Deficiency","author":"JP Monson","year":"2000","unstructured":"Monson JP, Brooke AM, Akker S. Adult Growth Hormone Deficiency. In: Endotext LJ, Groot D, et al., editors. . South Dartmouth (MA).: MDText.com, Inc.:; 2000."},{"issue":"1","key":"9378_CR80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","volume":"16","author":"H Boer de","year":"1995","unstructured":"de Boer H, Blok GJ, Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 1995;16(1):63\u201386.","journal-title":"Endocr Rev"},{"issue":"6","key":"9378_CR81","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1210\/jc.2012-4012","volume":"98","author":"S Melmed","year":"2013","unstructured":"Melmed S. Idiopathic adult growth hormone deficiency. J Clin Endocrinol Metab. 2013;98(6):2187\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9378_CR82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/archdischild-2014-307228","volume":"101","author":"PG Murray","year":"2016","unstructured":"Murray PG, Dattani MT, Clayton PE. Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence. Arch Dis Child. 2016;101(1):96\u2013100.","journal-title":"Arch Dis Child"},{"issue":"Suppl 1","key":"9378_CR83","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1530\/eje.0.151S011","volume":"151","author":"RG Rosenfeld","year":"2004","unstructured":"Rosenfeld RG, Hwa V. New molecular mechanisms of GH resistance. Eur J Endocrinol. 2004;151(Suppl 1):S11\u20135.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9378_CR84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ng0298-147","volume":"18","author":"W Wu","year":"1998","unstructured":"Wu W et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet. 1998;18(2):147\u20139.","journal-title":"Nat Genet"},{"issue":"5","key":"9378_CR85","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2265.1992.tb02347.x","volume":"37","author":"RC Cuneo","year":"1992","unstructured":"Cuneo RC et al. The growth hormone deficiency syndrome in adults. Clin Endocrinol. 1992;37(5):387\u201397.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"9378_CR86","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2265.2006.02631.x","volume":"65","author":"F Tanriverdi","year":"2006","unstructured":"Tanriverdi F et al. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6\u00a0months of GH replacement therapy: a randomized placebo controlled study. Clin Endocrinol. 2006;65(5):579\u201385.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"9378_CR87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/B:PITU.0000023425.20854.8e","volume":"6","author":"F Kelestimur","year":"2003","unstructured":"Kelestimur F. Sheehan\u2019s syndrome. Pituitary. 2003;6(4):181\u20138.","journal-title":"Pituitary"},{"issue":"2","key":"9378_CR88","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-3083.2006.01898.x","volume":"21","author":"M Borlu","year":"2007","unstructured":"Borlu M et al. The effects of severe growth hormone deficiency on the skin of patients with Sheehan\u2019s syndrome. J Eur Acad Dermatol Venereol. 2007;21(2):199\u2013204.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"9378_CR89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2265.1997.2021027.x","volume":"47","author":"GJ Blok","year":"1997","unstructured":"Blok GJ et al. Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clin Endocrinol. 1997;47(1):29\u201336.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"9378_CR90","first-page":"92","volume":"54","author":"F Conte","year":"2000","unstructured":"Conte F et al. Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient children. Horm Res. 2000;54(2):92\u20137.","journal-title":"Horm Res"},{"issue":"5","key":"9378_CR91","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/00365519109091642","volume":"51","author":"K Main","year":"1991","unstructured":"Main K, Nilsson KO, Skakkebaek NE. Influence of sex and growth hormone deficiency on sweating. Scand J Clin Lab Invest. 1991;51(5):475\u201380.","journal-title":"Scand J Clin Lab Invest"},{"key":"9378_CR92","doi-asserted-by":"crossref","unstructured":"Raynal P. Growth hormone and noonan syndrome: update in dysfunctional signaling aspects and in therapy for short stature. Hormonal Studies. 2014;2(1).","DOI":"10.7243\/2052-8000-2-1"},{"issue":"6","key":"9378_CR93","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2147\/TCRM.S1440","volume":"4","author":"BE Spiliotis","year":"2008","unstructured":"Spiliotis BE. Recombinant human growth hormone in the treatment of Turner syndrome. Ther Clin Risk Manag. 2008;4(6):1177\u201383.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"9378_CR94","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng0597-54","volume":"16","author":"E Rao","year":"1997","unstructured":"Rao E et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet. 1997;16(1):54\u201363.","journal-title":"Nat Genet"},{"issue":"2","key":"9378_CR95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4274\/jcrpe.1228","volume":"6","author":"Z Aycan","year":"2014","unstructured":"Aycan Z, Bas VN. Prader-Willi syndrome and growth hormone deficiency. J Clin Res Pediatr Endocrinol. 2014;6(2):62\u20137.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"5","key":"9378_CR96","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2003.07.031","volume":"50","author":"EJ Lowenstein","year":"2004","unstructured":"Lowenstein EJ, Kim KH, Glick SA. Turner\u2019s syndrome in dermatology. J Am Acad Dermatol. 2004;50(5):767\u201376.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"9378_CR97","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajmg.1320210312","volume":"21","author":"HM Mendez","year":"1985","unstructured":"Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet. 1985;21(3):493\u2013506.","journal-title":"Am J Med Genet"},{"issue":"2","key":"9378_CR98","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/adc.67.2.178","volume":"67","author":"M Sharland","year":"1992","unstructured":"Sharland M et al. A clinical study of Noonan syndrome. Arch Dis Child. 1992;67(2):178\u201383.","journal-title":"Arch Dis Child"},{"issue":"1","key":"9378_CR99","first-page":"37","volume":"89","author":"V Bhambhani","year":"2014","unstructured":"Bhambhani V, Muenke M. Noonan syndrome. Am Fam Physician. 2014;89(1):37\u201343.","journal-title":"Am Fam Physician"},{"issue":"1","key":"9378_CR100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1542\/peds.2010-2820","volume":"127","author":"SE McCandless","year":"2011","unstructured":"McCandless SE. Clinical report-health supervision for children with Prader-Willi syndrome. Pediatrics. 2011;127(1):195\u2013204.","journal-title":"Pediatrics"},{"issue":"3","key":"9378_CR101","first-page":"129","volume":"90","author":"E Bornhausen-Demarch","year":"2012","unstructured":"Bornhausen-Demarch E et al. Cutaneous manifestations of Prader-Willi syndrome. Cutis. 2012;90(3):129\u201331.","journal-title":"Cutis"},{"issue":"5","key":"9378_CR102","first-page":"827","volume":"72","author":"DJ Wattendorf","year":"2005","unstructured":"Wattendorf DJ, Muenke M. Prader-Willi syndrome. Am Fam Physician. 2005;72(5):827\u201330.","journal-title":"Am Fam Physician"},{"issue":"4","key":"9378_CR103","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000077839","volume":"208","author":"R Lurie","year":"2004","unstructured":"Lurie R, Ben-Amitai D, Laron Z. Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatology. 2004;208(4):314\u20138.","journal-title":"Dermatology"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9378-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-016-9378-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9378-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9378-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T08:45:13Z","timestamp":1657183513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-016-9378-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9378"],"URL":"https:\/\/doi.org\/10.1007\/s11154-016-9378-8","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]}}}